Chapter 1. Introduction
1.1. Report Description And Scope
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
Chapter 2. Executive Summary
2.1. Global generic drugs market , 2015 - 2021 (USD Billion)
2.2. Global generic drugs market : Snapshot
Chapter 3. Generic Drugs Market Market Dynamics
3.1. Introduction
3.2. Value Chain Analysis
3.3. Market Drivers
3.3.1. Global generic drugs market Drivers: Impact Analysis
3.3.2. increasing number of patent expiration of branded drugs and government initiatives
3.3.3. increase in prevalence of chronic diseases and emerging markets
3.4. Market Restraints
3.4.1. Global generic drugs market Restraints: Impact Analysis
3.4.2. High competition and shortage of generic drugs.
3.5. Opportunities
3.5.1. Untapped and emerging markets like India and China
3.6. Porters Five Forces Analysis
3.6.1. Bargaining Power Of Suppliers
3.6.2. Bargaining Power Of Buyers
3.6.3. Threat From New Entrants
3.6.4. Threat From New Substitutes
3.6.5. Degree Of Competition
3.7. Market Attractiveness Analysis
3.7.1. Market Attractiveness Analysis, By Brand segment
3.7.2. Market Attractiveness Analysis, By Therapeutic application segment
3.7.3. Market Attractiveness Analysis, By Regional Segment
Chapter 4. Global generic drugs market Competitive Landscape
4.1. Company Market Share, 2014 (Subject To Data Availability)
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Source Launch
4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
4.2.4. Research And Development, Product And Regional Expansion
4.3. Product Portfolio
Chapter 5. Global generic drugs market Brand Analysis
5.1. Global generic drugs market : Brand Segment Overview
5.1.1. Global generic drugs market Revenue Share, By Brand Segment, 2015 And 2021
5.2. Pure generic drugs
5.2.1. Global generic drugs market for Pure generic drugs, 2015 - 2021 (USD Billion)
5.3. Branded generic drugs
5.3.1. Global generic drugs market for Branded generic drugs, 2015 - 2021 (USD Billion)
Chapter 6. Global generic drugs market Therapeutic application Analysis
6.1. Global generic drugs market : Therapeutic application Segment Overview
6.1.1. Global generic drugs market Revenue Share, By Therapeutic application Segment, 2015 And 2021
6.2. Central nervous system (CNS)
6.2.1. Global generic drugs market For Central nervous system (CNS), 2015 - 2021 (USD Billion)
6.3. Cardiovascular
6.3.1. Global generic drugs market For Cardiovascular, 2015 - 2021 (USD Billion
6.4. Dermatology
6.4.1. Global generic drugs market For Dermatology, 2015 - 2021 (USD Billion
6.5. Oncology
6.5.1. Global generic drugs market For Oncology, 2015 - 2021 (USD Billion
6.6. Respiratory
6.6.1. Global generic drugs market For Respiratory, 2015 - 2021 (USD Billion
6.7. Others
6.7.1. Global generic drugs market For Others, 2015 - 2021 (USD Billion
Chapter 7. Global generic drugs market Regional Segment Analysis
7.1. Global generic drugs market : Regional Overview
7.1.1. Global generic drugs market Revenue Share, By Region, 2014 And 2020
7.2. North America
7.2.1. North America generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)
7.2.2. North America generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)
7.2.3. U.S.
7.2.3.1. U.S. generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)
7.2.3.2. U.S. generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)
7.3. Europe
7.3.1. Europe generic drugs market Revenue, by brand, 2015 - 2021 (USD Billion)
7.3.2. Europe generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)
7.3.3. U.K.
7.3.3.1. U.K. generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)
7.3.3.2. U.K. generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)
7.3.4. France
7.3.4.1. U.K. generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)
7.3.4.2. U.K. generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)
7.3.5. Germany
7.3.5.1. Germany generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)
7.3.5.2. Germany generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific generic drugs market Revenue, by brand, 2015 - 2021 (USD Billion)
7.4.2. Asia Pacific generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)
7.4.3. China
7.4.3.1. China generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)
7.4.3.2. China generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)
7.4.4. Japan
7.4.4.1. Japan generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)
7.4.4.2. Japan generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)
7.4.5. India
7.4.5.1. India generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)
7.4.5.2. India generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)
7.5. Latin America
7.5.1. Latin America Generic drugs market Revenue, by brand, 2015 - 2021 (USD Billion)
7.5.2. Brazil
7.5.2.1. Brazil generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)
7.5.2.2. Brazil generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)
Chapter 8. Company Profile
8.1. Teva Pharmaceutical Industries Ltd.
8.1.1. Overview
8.1.2. Financials
8.1.3. Product Portfolio
8.1.4. Business Strategy
8.1.5. Recent Developments
8.2. Novartis International AG.
8.2.1. Overview
8.2.2. Financials
8.2.3. Product Portfolio
8.2.4. Business Strategy
8.2.5. Recent Developments
8.3. Mylan N.V.
8.3.1. Overview
8.3.2. Financials
8.3.3. Product Portfolio
8.3.4. Business Strategy
8.3.5. Recent Developments
8.4. Abbott Healthcare Pvt Ltd.
8.4.1. Overview
8.4.2. Financials
8.4.3. Product Portfolio
8.4.4. Business Strategy
8.4.5. Recent Developments
8.5. Actavis pharmaceuticals Overview
8.5.1. Financials
8.5.2. Product Portfolio
8.5.3. Business Strategy
8.5.4. Recent Developments
8.6. Sun Pharmaceutical Industries Limited Overview
8.6.1. Financials
8.6.2. Product Portfolio
8.6.3. Business Strategy
8.6.4. Recent Developments